Vector Science & Therapeutics Expands its Distributor Network for Peptide Products Across Key Medical Channels#United_States#Vector_Science#Distributor_Network#Peptide_Portfolio#Mequon,_Wisconsin
Vector Science & Therapeutics Expands its Distributor Network for Peptide Products Across Key Medical Channels
Vector Science & Therapeutics is developing a dedicated distributor network to enhance its peptide portfolio in orthopedics and regenerative medicine.
third-news.com
July 21, 2026 at 2:11 PM
Vector Science & Therapeutics Expands its Distributor Network for Peptide Products Across Key Medical Channels#United_States#Vector_Science#Distributor_Network#Peptide_Portfolio#Mequon,_Wisconsin
Vector Science and Therapeutics Corp. Signs Agreement with RedChip for Investor Relations Support#Investor_Relations#RedChip#Vector_Science
Vector Science and Therapeutics Corp. Signs Agreement with RedChip for Investor Relations Support
Vector Science and Therapeutics Corp. has entered into a strategic investor relations agreement with RedChip Companies to enhance its outreach and communication.
third-news.com
August 26, 2026 at 12:39 AM
Vector Science and Therapeutics Corp. Signs Agreement with RedChip for Investor Relations Support#Investor_Relations#RedChip#Vector_Science
Vector Science & Therapeutics Launches Peptide Production at New Manufacturing Facility#Canada#Mequon#Peptide_Production#Vector_Science#LyoGenesis
Vector Science & Therapeutics Launches Peptide Production at New Manufacturing Facility
Vector Science & Therapeutics has initiated peptide production in its new facility. This milestone positions the company to fulfill significant customer demand.
third-news.com
August 24, 2026 at 11:37 AM
Vector Science & Therapeutics Launches Peptide Production at New Manufacturing Facility#Canada#Mequon#Peptide_Production#Vector_Science#LyoGenesis
Vector Science and Therapeutics' New Patent for Orthopedic Tissue Healing Innovations#United_States#Pain_Management#Orthopedic_Surgery#Mequon#Vector_Science
Vector Science and Therapeutics' New Patent for Orthopedic Tissue Healing Innovations
Vector Science and Therapeutics Corp. has filed a provisional patent for an integrated platform aimed at enhancing orthopedic tissue regeneration using peptides and autologous biologics.
third-news.com
August 20, 2026 at 11:36 AM
Vector Science and Therapeutics' New Patent for Orthopedic Tissue Healing Innovations#United_States#Pain_Management#Orthopedic_Surgery#Mequon#Vector_Science
Verlytix: Elevating Pharmaceutical Testing Through Strategic Launch#USA#Mequon#Vector_Science#LyoGenesis#Verlytix
Verlytix: Elevating Pharmaceutical Testing Through Strategic Launch
Verlytix has launched its innovative quality testing platform, enhancing its pharmaceutical testing capabilities while aligning with LyoGenesis Manufacturing.
third-news.com
August 18, 2026 at 12:37 PM
Verlytix: Elevating Pharmaceutical Testing Through Strategic Launch#USA#Mequon#Vector_Science#LyoGenesis#Verlytix
Long-Term Partnership: Vector Science Embarks on Decade with LyoGenesis for Manufacturing Agreement#United_States#Mequon#Vector_Science#Pharmaceutical_Products#LyoGenesis
Long-Term Partnership: Vector Science Embarks on Decade with LyoGenesis for Manufacturing Agreement
Vector Science and Therapeutics has secured a long-term manufacturing agreement with LyoGenesis, ensuring stable production capacity for its peptide platform.
third-news.com
August 17, 2026 at 11:56 AM
Long-Term Partnership: Vector Science Embarks on Decade with LyoGenesis for Manufacturing Agreement#United_States#Mequon#Vector_Science#Pharmaceutical_Products#LyoGenesis
Strategic Alliance Announced by Vector Science and Wynn Pharmaceuticals for Critical Care Solutions#USA#Mequon#Vector_Science#LyoGenesis_Plus#Wynn_Pharmaceuticals
Strategic Alliance Announced by Vector Science and Wynn Pharmaceuticals for Critical Care Solutions
Vector Science & Therapeutics Corp. and Wynn Pharmaceuticals have formed a strategic partnership to develop and manufacture critical care medical products, enhancing healthcare delivery.
third-news.com
July 28, 2026 at 11:37 AM
Strategic Alliance Announced by Vector Science and Wynn Pharmaceuticals for Critical Care Solutions#USA#Mequon#Vector_Science#LyoGenesis_Plus#Wynn_Pharmaceuticals
Vector Science & Therapeutics Expands Patent Portfolio for Innovative Drug Delivery Solutions#United_States#Mequon#Patent_Portfolio#Vector_Science#Therapeutic_Delivery
Vector Science & Therapeutics Expands Patent Portfolio for Innovative Drug Delivery Solutions
Vector Science & Therapeutics has grown its patent portfolio to 15 applications focused on precision delivery of peptides and biologics, aiming to enhance therapeutic efficacy.
third-news.com
July 15, 2026 at 11:52 AM
Vector Science & Therapeutics Expands Patent Portfolio for Innovative Drug Delivery Solutions#United_States#Mequon#Patent_Portfolio#Vector_Science#Therapeutic_Delivery
Darryl Drake Jr. Takes the Helm as President of Valor at Vector Science and Therapeutics#USA#San_Bernardino#Vector_Science#Performance_Medicine#Darryl_Drake
Darryl Drake Jr. Takes the Helm as President of Valor at Vector Science and Therapeutics
Vector Science and Therapeutics has appointed Darryl Drake Jr. as President of Valor, aiming to revolutionize performance medicine for athletes and entertainers globally.
third-news.com
July 8, 2026 at 6:33 PM
Darryl Drake Jr. Takes the Helm as President of Valor at Vector Science and Therapeutics#USA#San_Bernardino#Vector_Science#Performance_Medicine#Darryl_Drake
Vector Science & Therapeutics Partners with LyoGenesis for Innovative Peptide Production#United_States#Mequon#Vector_Science#LyoGenesis#Peptide_Technology
Vector Science & Therapeutics Partners with LyoGenesis for Innovative Peptide Production
Vector Science & Therapeutics announces a significant exclusive manufacturing deal with LyoGenesis, enhancing their peptide delivery technology and market reach.
third-news.com
July 7, 2026 at 11:57 AM
Vector Science & Therapeutics Partners with LyoGenesis for Innovative Peptide Production#United_States#Mequon#Vector_Science#LyoGenesis#Peptide_Technology
Vector Science & Therapeutics Announces Revolutionary Transdermal Delivery System for Peptide Therapies#USA#Mequon#Therapeutics#Vector_Science#Transdermal_Delivery
Vector Science & Therapeutics Announces Revolutionary Transdermal Delivery System for Peptide Therapies
Vector Science & Therapeutics has filed a provisional patent for a novel transdermal delivery platform utilizing pulsed magnetic fields to administer peptide therapeutics effectively without injections.
third-news.com
June 30, 2026 at 12:57 PM
Vector Science & Therapeutics Announces Revolutionary Transdermal Delivery System for Peptide Therapies#USA#Mequon#Therapeutics#Vector_Science#Transdermal_Delivery
Gary Payton II Takes on Role as Chief Athletic Ambassador at Valor#USA#Wisconsin#Valor#Vector_Science#Gary_Payton_II
Gary Payton II Takes on Role as Chief Athletic Ambassador at Valor
NBA Champion Gary Payton II has been appointed as Chief Athletic Ambassador at Valor, focusing on innovative injury recovery for athletes.
third-news.com
June 22, 2026 at 11:44 AM
Gary Payton II Takes on Role as Chief Athletic Ambassador at Valor#USA#Wisconsin#Valor#Vector_Science#Gary_Payton_II
Dexter Fowler Takes On Chief Athletic Officer Role at Valor to Transform Sports Medicine#USA#Valor#Mequon#Vector_Science#Dexter_Fowler
Dexter Fowler Takes On Chief Athletic Officer Role at Valor to Transform Sports Medicine
Vector Science & Therapeutics welcomes Dexter Fowler as Chief Athletic Officer for Valor, aiming to enhance athlete care and longevity through innovative solutions.
third-news.com
June 12, 2026 at 11:24 AM
Dexter Fowler Takes On Chief Athletic Officer Role at Valor to Transform Sports Medicine#USA#Valor#Mequon#Vector_Science#Dexter_Fowler
Darryl Drake Jr. Appointed as President of Valor Division at Vector Science & Therapeutics#USA#Mequon#Vector_Science#Darryl_Drake_Jr.#Valor_Division
Darryl Drake Jr. Appointed as President of Valor Division at Vector Science & Therapeutics
Vector Science & Therapeutics recently announced the appointment of Darryl Drake Jr. as President of its newly formed Valor division, specializing in sports medicine.
third-news.com
June 8, 2026 at 11:53 AM
Darryl Drake Jr. Appointed as President of Valor Division at Vector Science & Therapeutics#USA#Mequon#Vector_Science#Darryl_Drake_Jr.#Valor_Division
Vector Science & Therapeutics Corp. Provides Stock Options to Strengthen Growth Strategy#Canada#stock_options#Growth_Strategy#Mequon#Vector_Science
Vector Science & Therapeutics Corp. Provides Stock Options to Strengthen Growth Strategy
Vector Science & Therapeutics has announced a new grant of stock options, reinforcing its strategic growth plans. The company demonstrates commitment to its future.
third-news.com
June 2, 2026 at 11:48 AM
Vector Science & Therapeutics Corp. Provides Stock Options to Strengthen Growth Strategy#Canada#stock_options#Growth_Strategy#Mequon#Vector_Science
Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement#USA#Mequon#MPP_Group#Vector_Science#LyoGenesis_Plus
Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement
Vector Science & Therapeutics has entered a significant option agreement with LyoGenesis Plus, marking a robust step into the peptide market with FDA-registered manufacturing.
third-news.com
May 14, 2026 at 12:12 AM
Vector Science & Therapeutics Secures Long-Term Manufacturing with LyoGenesis Plus Option Agreement#USA#Mequon#MPP_Group#Vector_Science#LyoGenesis_Plus
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing#USA#Mequon#MPP_Group#Vector_Science#Peptide_Market
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing
Vector Science & Therapeutics has signed a three-year deal with MPP Group LLC to develop pharmaceutical-grade peptide formulations. This agreement enhances Vector's entry into the expanding peptide market valued at $80.8 billion.
third-news.com
May 11, 2026 at 12:58 PM
Vector Science & Therapeutics Partners with MPP Group to Innovate in Peptide Development and Manufacturing#USA#Mequon#MPP_Group#Vector_Science#Peptide_Market
Vector Science & Therapeutics Strengthens Board with Key Appointments for Future Success#USA#Mequon#Scott_Kelly#Vector_Science#Dr._Dobranowski
Vector Science & Therapeutics Strengthens Board with Key Appointments for Future Success
Vector Science & Therapeutics enhances its leadership team with the appointment of Dr. Dobranowski and Scott Kelly to its Board, boosting strategic capabilities.
third-news.com
May 6, 2026 at 1:46 PM
Vector Science & Therapeutics Strengthens Board with Key Appointments for Future Success#USA#Mequon#Scott_Kelly#Vector_Science#Dr._Dobranowski
Vector Science & Therapeutics Innovates with Microneedle Catheter for Targeted Cancer Treatment#United_States#Cancer_Treatment#Mequon#Vector_Science#Microneedle_Catheter
Vector Science & Therapeutics Innovates with Microneedle Catheter for Targeted Cancer Treatment
Vector Science & Therapeutics has filed a provisional patent for an innovative microneedle catheter aimed at enhancing drug delivery for pancreatic cancer treatments, promising more effective therapies.
third-news.com
May 1, 2026 at 1:39 PM
Vector Science & Therapeutics Innovates with Microneedle Catheter for Targeted Cancer Treatment#United_States#Cancer_Treatment#Mequon#Vector_Science#Microneedle_Catheter
Tommy Thompson Appointed as Chairman of Vector Science & Therapeutics Board#United_States#Healthcare_Leadership#Mequon#Tommy_Thompson#Vector_Science
Tommy Thompson Appointed as Chairman of Vector Science & Therapeutics Board
Tommy Thompson, former Governor of Wisconsin, becomes Chairman of Vector Science & Therapeutics, enhancing the company's healthcare expertise as it pioneers innovative drug delivery systems.
third-news.com
April 30, 2026 at 12:44 PM
Tommy Thompson Appointed as Chairman of Vector Science & Therapeutics Board#United_States#Healthcare_Leadership#Mequon#Tommy_Thompson#Vector_Science
Vector Science & Therapeutics Welcomes Tabitha Hendren as New Engineering Director#United_States#Engineering#Lodi#Tabitha_Hendren#Vector_Science
Vector Science & Therapeutics Welcomes Tabitha Hendren as New Engineering Director
Vector Science & Therapeutics has appointed Tabitha Hendren as the new Director of Engineering and Design, enhancing its commitment to innovation in medical devices.
third-news.com
October 2, 2025 at 12:35 PM
Vector Science & Therapeutics Welcomes Tabitha Hendren as New Engineering Director#United_States#Engineering#Lodi#Tabitha_Hendren#Vector_Science